Mannix Pharma (OPC) Private Limited

Mannix Pharma (OPC) Private Limited - business services in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74999DL2018OPC335193 Incorporated 12 June 2018 ROC Delhi HQ New Delhi, Delhi, India
Active business services MSME · Micro
Data last updated
Revenue · FY 2025
₹63,803
▲ 109.74% YoY
Net loss · FY 2025
₹8,943
Net margin -14%
EBITDA · FY 2025
-₹8,943
EBITDA margin -14%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹50,000
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
1
As per MCA filings
Active GSTINs
1
GST registered

About Mannix Pharma (OPC) Private Limited

Data last updated:

Mannix Pharma (OPC) Private Limited is a one person company based in New Delhi, Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 12 June 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018OPC335193. Its GSTIN is 07AALCM9044L1ZW (Delhi).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹50,000. It is led by director Shivani Varthval.

Its latest financial statements are for the year ended 31 March 2025. The registered office is at Space No – 303 At P.No – 20 Shivam Tower Complex Paschim Vihar, New Delhi, Delhi, India – 110063.

As per the financials filed for FY 2025, the company reported a revenue of ₹63,803. For the same year it recorded a net loss of ₹8,943 (net margin -14%) and EBITDA of -₹8,943 (EBITDA margin -14%). Revenue has declined at a compounded annual rate (CAGR) of 54% over three years and 38% over five years.

Mannix Pharma (OPC) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0059667).

Company details

CIN U74999DL2018OPC335193
Registration Number 335193
Incorporation Date 12 June 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0059667
Key People
Shivani Varthval Director

Recognitions & Rankings of Mannix Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-11-0059667

Contact details

Mannix Pharma (OPC) Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Space No – 303 At P.No – 20 Shivam Tower Complex Paschim Vihar, New Delhi, Delhi, India – 110063
  • Industry
    Business Services, Other Services, Miscellaneous Business Activities

To see the full contact details of Mannix Pharma (OPC) Private Limited, buy the company report.

Comprehensive company report
Mannix Pharma (OPC) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Mannix Pharma is human health and social work activities. In detail, this covers human health activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHuman health and social work activities86Human health activities

To see the full business activity and turnover split of Mannix Pharma (OPC) Private Limited, buy the company report.

Financials of Mannix Pharma (OPC) Private Limited

FY 2025 filings available

Mannix Pharma (OPC) Private Limited reported revenue of ₹63,803 for FY 2025.

Revenue · FY 2025
₹63,803
Net loss · FY 2025
₹8,943 margin -14%
EBITDA · FY 2025
-₹8,943 margin -14%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▼ 54%
5 years · compounded
▼ 38%
EBITDA CAGR growth
1 year
▲ 55%
3 years · compounded
▼ 47%
5 years · compounded
▼ 17%

Revenue has declined at a compounded annual rate (CAGR) of 38% over five years. EBITDA rose 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹8,943
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹8,943
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-14%
Net Profit Margin-14%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Mannix Pharma (OPC) Private Limited, buy the company report.

Board of directors of Mannix Pharma (OPC) Private Limited

Mannix Pharma has 1 current director and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shivani VarthvalDirector12 Jun 20188 Years 4 MonthsCurrent
View all directors

MSME payment delays

No delayed payments to MSME suppliers are on our record for Mannix Pharma (OPC) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Mannix Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AALCM9044L1ZWDelhiActive12 Jul 2018

To see the full GST registrations and return filing status of Mannix Pharma (OPC) Private Limited, buy the company report.

Recent activity

Mannix Pharma (OPC) Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Krishan was appointed as Nominee on 12 Jun 2018.

Filing
Mannix Pharma (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Krishan was appointed as Nominee.
Appointed
Shivani Varthval was appointed as Director.
Incorporation
12 Jun 2018
Mannix Pharma (Opc) Private Limited was registered on 12 Jun 2018 with Roc Delhi & aged 8 years 4 months as per MCA records.

Frequently asked questions

Mannix Pharma is an active company based in New Delhi, Delhi, India. The company works in other services, within the business services industry. It was incorporated on 12 June 2018 (8+ years old) and is registered under CIN U74999DL2018OPC335193.

Mannix Pharma has 1 current director:

The latest financial statements of Mannix Pharma on record with the MCA are for the year ended 31 March 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Mannix Pharma is 07AALCM9044L1ZW, registered in Delhi.

The CIN (Corporate Identification Number) of Mannix Pharma is U74999DL2018OPC335193. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Mannix Pharma was incorporated on 12 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.

Krishan was appointed as Nominee on 12 Jun 2018. Shivani Varthval was appointed as Director on 12 Jun 2018.

Yes, Mannix Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0059667).

The registered office of Mannix Pharma is at Space No – 303 At P.No – 20 Shivam Tower Complex Paschim Vihar, New Delhi, Delhi, India – 110063.

Mannix Pharma operates in the business services industry, in the other services segment.